Oncotelic Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1992
Net Income	-7.9	17.82	-11.39	-11.5	-7.39	-2.74	-13.81	-13.65	-13.65	-12.65	Upgrade
Depreciation & Amortization	0	0.01	0.06	0.36	0.06	0	0.01	0.02	0.02	0.11	Upgrade
Share-Based Compensation	0	0.9	0.76	2.15	0.34	0.74	0.84	0.8	0.81	0.41	Upgrade
Other Operating Activities	6.58	-20.19	6.13	6.18	4.71	-0.85	2.04	-2.41	0.9	-0.03	Upgrade
Operating Cash Flow	-1.32	-1.45	-4.43	-2.81	-2.28	-2.84	-10.93	-15.24	-11.93	-12.15	Upgrade
Capital Expenditures	0	0	0	0	0	0	0	0	-0.01	-0.02	Upgrade
Acquisitions	0	0	0	0	0.19	0	0	0	0	0	Upgrade
Change in Investments	-	-	-	-	-	-	-8.51	-33.52	-	-	Upgrade
Other Investing Activities	-	-	-	-	-	-	17.02	25	-	-	Upgrade
Investing Cash Flow	0	0	0	0	0.19	0	8.51	-8.51	-0.01	-0.02	Upgrade
Common Stock Issued	0	0.16	1.97	2.93	0.08	2.36	0	0	9.19	25.68	Upgrade
Share Repurchases	-0.13	0	0	0	0	0	0	0	0	0	Upgrade
Other Financing Activities	1.13	0.97	2.56	0.3	2.09	-	-	-	-	9.51	Upgrade
Financing Cash Flow	1.25	1.13	4.53	3.22	2.17	2.36	0	0	9.19	35.19	Upgrade
Net Cash Flow	-0.07	-0.33	0.09	0.41	0.08	-0.49	-2.42	-23.75	-2.75	23.03	Upgrade
Free Cash Flow	-1.32	-1.45	-4.43	-2.81	-2.28	-2.84	-10.93	-15.24	-11.94	-12.17	Upgrade
Free Cash Flow Margin	-1887.21%	-	-	-161.53%	-	-	-	-	-	-12808.42%	Upgrade
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.03	-0.04	-0.08	-0.41	-0.57	-0.47	-0.72	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.